Press release
Global Leukemia Market Report - Forecasts to 2026
The findings reviewed by GME stated that the Global Leukemia Market will expand at a CAGR value of 6.52% to reach USD 19.52 billion by 2026 from USD 13.21 billion by 2021. The factors supporting the leukemia market growth are the rising incidence of acute & chronic myeloid leukemia, rising research and developmental activities to launch non-invasive and advanced therapeutics for cancer treatment, increasing government expenditure on healthcare infrastructure and growing government initiatives for cancer awareness.Browse 153 Market Data Tables and 113 Figures spread through 183 Pages and in-depth TOC on “Global Leukemia Market” - Forecast to 2026” https://www.globalmarketestimates.com/market-report/leukemia-market-3371
By Type (Chronic Myeloid Leukemia, Chronic Lymphocytic Leukemia, Acute Lymphocytic Leukemia, Acute Myeloid Leukemia), By Treatment Type (Chemotherapy, Targeted Drugs & Immunotherapy), By Molecule Type (Biologics, Small Molecules), By Mode of Administration (Oral Mode, Injectable Mode), By Region (North America, Europe, Asia Pacific, MEA, and CSA); End-User Landscape, Vendor Landscape, and Company Market Share Analysis and Competitor Analysis
Key Market Insights:
• The targeted drugs segment will be the largest shareholder of the market owing to the increasing demand for targeted drugs. As compared to chemotherapy, targeted medications are the most extensively utilized as they have fewer side effects and a greater efficacy and success rate.
• The chemotherapy segment will be the fastest-growing segment with the highest CAGR value from 2021 to 2026 due to rising cases of leukemia.
• Rising investments in research & innovation activities, growing disposable income, and increasing awareness of leukemia will impact the leukemia cancer market trends positively in the APAC region
• F. Hoffmann-La Roche AG, Bristol-Myers Squibb Company, AbbVie, Inc., Sanofi, Amgen, Gilead Sciences, Celgene Corporation, Pfizer, Inc., Novartis AG, and Takeda Pharmaceutical Company Limited, among others are some of the key players in the market.
• In January 2019, Amgen announced that it bagged the European Commission (EC) approval for BLINCYTO monotherapy. This helped the company expand its product portfolio and enhance its presence in the global leukemia market
Browse the Report @ https://www.globalmarketestimates.com/market-report/leukemia-market-3371
Based on Type Outlook (Revenue, USD Billion, 2021 - 2026)
• Chronic Myeloid Leukemia
• Chronic Lymphocytic Leukemia
• Acute Lymphocytic Leukemia
• Acute Myeloid Leukemia
Based on Treatment Type Outlook (Revenue, USD Billion, 2021 - 2026)
• Chemotherapy
• Targeted Drugs & Immunotherapy
Based on Molecule Type Outlook (Revenue, USD Billion, 2021 - 2026)
• Small Molecule
• Biologics
Based on Mode of Administration Outlook (Revenue, USD Billion, 2021 - 2026)
• Oral Mode
• Injectable Mode
Regional Outlook (Revenue, USD Billion, 2021 – 2026)
• North America
• The U.S.
• Canada
• Mexico
• Europe
• Germany
• UK
• France
• Spain
• Italy
• Rest of Europe
• Asia Pacific
• China
• India
• Japan
• South Korea
• Australia
• Rest of APAC
• Central & South America
• Brazil
• Argentina
• Chile
• Rest of CSA
• Middle East & Africa
• Saudi Arabia
• South Africa
• UAE
• Rest of MEA
Contact: Yash Jain
Email address: yash.jain@globalmarketestimates.com
Phone Number: +16026667238
Website: https://www.globalmarketestimates.com
Check our Latest Blogs: https://www.globalmarketestimates.com/blog-posts.php
B-502, Kemp Plaza, Mindspace, Malad West, Mumbai: 400 064, India
Global Market Estimates is an India based market research and consulting company. The company provides syndicated research reports, customised research reports and consulting services to their clients and helps them achieve their business goals on a commercial level. Global Market Estimates database is used by the world's well known and prolific academic institutions and Fortune 500 companies to understand the global and regional business environment to excel in their business goals.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Leukemia Market Report - Forecasts to 2026 here
News-ID: 2327216 • Views: …
More Releases from Global Market Estimates Research & Consultants

Global Market Estimates Hosts Exclusive Webinar on Future Trends in Quick Commer …
Gain Strategic Insights and a Comprehensive Report on August 1st
Global Market Estimates (GME) is excited to announce an exclusive webinar, "Future Trends in the Global Quick Commerce Market: Forecasts to 2029," scheduled for August 1, 2024, at 11am EST. This insightful session will feature Mr. Yash Jain, Director - Global Accounts & Strategic Advisory.
For a registration fee of USD 499, attendees will receive a comprehensive report valued at USD 5,450,…

Global Flare Monitoring Market Size & Trends
According to a new market research report published by Global Market Estimates, the global flare monitoring market is expected to grow at a CAGR of 6.5% from 2024 to 2029.
Global flare monitoring market growth is driven by factors such as safety and risk management and growing emphasis on reduction of emissions.
Unlock the Executive Summary of the report at only USD 249. Book a call now: https://tidycal.com/yashsushiljain/unlock-strategic-insights-press-release
Key Market Insights
• As per…

Global Fiber Optic Component System Market Size & Trends
According to a new market research report published by Global Market Estimates, the global fiber optic component system market is expected to grow at a CAGR of 8.46 % from 2024 to 2029.
Global fiber optic component system market growth is driven by factors such as growing demand for safety regulations and technological developments.
Unlock the Executive Summary of the report at only USD 249. Book a call now: https://tidycal.com/yashsushiljain/unlock-strategic-insights-press-release
Key Market…

Global Rechargeable Battery Market Size & Trends
According to a new market research report published by Global Market Estimates, the global rechargeable battery market is expected to grow at a CAGR of 15.4% from 2024 to 2029.
Rechargeable batteries have been growing in popularity due to their inherent superiority over disposable batteries in environmental pollution. As rechargeable batteries can be recharged after every use, they cause much lower environmental degradation as compared to disposable batteries, which are discarded…
More Releases for Leukemia
The Impact Of Increasing Leukemia Prevalence On The Leukemia Therapeutics Market …
The Leukemia Therapeutics Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Leukemia Therapeutics Market Size During the Forecast Period?
In recent times, the market size for leukemia therapeutics has seen robust growth. It is projected to increase from $17.57 billion in 2024…
Leukemia Therapeutics Market - Revolutionizing Leukemia Care: Cutting-Edge Thera …
Newark, New Castle, USA: The "Leukemia Therapeutics Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Leukemia Therapeutics Market: https://www.growthplusreports.com/report/leukemia-therapeutics-market/7759
This latest report researches the industry structure, sales, revenue,…
Acute Lymphoblastic Leukemia Therapeutics Market Size, Acute Lymphoblastic Leuke …
Acute Lymphoblastic Leukemia Therapeutics Market Dynamics are clarified by an in-depth review of facts on current and emerging trends. To understand a resource, the paper uses Porter's five forces to examine the importance of numerous qualities such as understanding of suppliers and customers, dangers provided by various agents, competitive strength, and promising new businesses. precious. Furthermore, the study covers numerous firms' Acute Lymphoblastic Leukemia Therapeutics research data, benefit, gross margin,…
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, T …
Orbisreserach.Com Adds “H1 Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Market Pipeline Review 2017 Trend Analysis Report Report” To Its Research Database
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, H1 2017, provides an overview of the Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) (Oncology) pipeline landscape.
Chronic myeloid leukemia (CML), also known as chronic myelogenous leukemia, is a type of cancer that starts in the blood-forming cells of the…
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Global Clinical T …
ReportsWorldwide has announced the addition of a new report title Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Global Clinical Trials Review, H1, 2017 to its growing collection of premium market research reports.
GlobalData's clinical trial report, “Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Global Clinical Trials Review, H1, 2017" provides an overview of Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) clinical trials scenario. This report provides top line data relating to…
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Global Clinical Tri …
ReportsWorldwide has announced the addition of a new report title Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Global Clinical Trials Review, H1, 2017 to its growing collection of premium market research reports.
GlobalData's clinical trial report, “Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Global Clinical Trials Review, H1, 2017" provides an overview of Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) clinical trials scenario. This report provides top line data relating to…